Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Uchino, K.
Right arrow Articles by Tirschwell, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Uchino, K.
Right arrow Articles by Tirschwell, D. L.
NEUROLOGY 2005;65:956-958
© 2005 American Academy of Neurology
Brief Communications

Moyamoya disease in Washington State and California

Ken Uchino, MD, S. Claiborne Johnston, MD, PhD, Kyra J. Becker, MD and David L. Tirschwell, MD, MSc

From the Department of Neurology (Dr. Uchino), University of Pittsburgh, Pittsburgh, PA; Departments of Neurology and Epidemiology (Dr. Johnston), University of California, San Francisco, CA; Department of Neurology (Drs. Becker and Tirschwell), Harborview Medical Center and University of Washington School of Medicine, Seattle, WA.

Address correspondence and reprint requests to Dr. Ken Uchino, UPMC Stroke Institute, 200 Lothrop Street, PUH C-400, Pittsburgh, PA 15213; e-mail: uchinok{at}upmc.edu

The authors identified 298 diagnoses of moyamoya in California and Washington from hospital discharge databases during the period 1987 to 1998. The incidence was 0.086/100,000 persons. The ethnicity-specific incidence rate ratios compared to whites were 4.6 (95% CI: 3.4 to 6.3) for Asian Americans, 2.2 (95% CI: 1.3 to 2.4) for African Americans, and 0.5 (95% CI: 0.3 to 0.8) for Hispanics. The incidence of moyamoya in Washington and California was lower than reported in Japan, but the rate among U.S. Asians is similar.

Supported by NIH/National Institute of Neurologic Disorders and Stroke grants K02NS02254 (S.C.J.), K02NS02160 (K.J.B.), and K23NS02119 (D.L.T.).

Disclosure: The authors report no conflicts of interest.

Received August 1, 2004. Accepted in final form May 25, 2005.




This article has been cited by other articles:


Home page
 JAOA: Journal of the American Osteopathic AssociationHome page
P. H. Janda, J. G. Bellew, and V. Veerappan
Moyamoya Disease: Case Report and Literature Review
J Am Osteopath Assoc, October 1, 2009; 109(10): 547 - 553.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
R. M. Scott and E. R. Smith
Moyamoya Disease and Moyamoya Syndrome
N. Engl. J. Med., March 19, 2009; 360(12): 1226 - 1237.
[Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
Picture of the Month--Diagnosis
Arch Pediatr Adolesc Med, February 1, 2009; 163(2): 180 - 180.
[Full Text] [PDF]

Home page
 StrokeHome page
E. S. Roach, M. R. Golomb, R. Adams, J. Biller, S. Daniels, G. deVeber, D. Ferriero, B. V. Jones, F. J. Kirkham, R. M. Scott, et al.
Management of Stroke in Infants and Children: A Scientific Statement From a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young
Stroke, September 1, 2008; 39(9): 2644 - 2691.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
T Baba, K Houkin, and S Kuroda
Novel epidemiological features of moyamoya disease
J. Neurol. Neurosurg. Psychiatry, August 1, 2008; 79(8): 900 - 904.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
J. F. Meschia and O. A. Ross
Heterogeneity of Moyamoya disease: After a decade of linkage, is there new hope for a gene?
Neurology, June 10, 2008; 70(24_Part_2): 2353 - 2354.
[Full Text] [PDF]

Home page
 StrokeHome page
S. Kuriyama, Y. Kusaka, M. Fujimura, K. Wakai, A. Tamakoshi, S. Hashimoto, I. Tsuji, Y. Inaba, and T. Yoshimoto
Prevalence and Clinicoepidemiological Features of Moyamoya Disease in Japan: Findings From a Nationwide Epidemiological Survey
Stroke, January 1, 2008; 39(1): 42 - 47.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
C. L. Hallemeier, K. M. Rich, R. L. Grubb Jr, M. R. Chicoine, C. J. Moran, D. T. Cross III, G. J. Zipfel, R. G. Dacey Jr, and C. P. Derdeyn
Clinical Features and Outcome in North American Adults With Moyamoya Phenomenon
Stroke, June 1, 2006; 37(6): 1490 - 1496.
[Abstract] [Full Text] [PDF]